Everybody talks about Alzheimer’s disease

William Klein · TEDxNIU 2014

William Klein talks about the issue of Alzheimer’s and how is has evolved over time. He speaks about how Alzheimer’s can even effect the economy. He responds to the question about what we can do about Alzheimer’s disease.

Dr. Klein’s research team is working on new ways to diagnose and treat Alzheimer’s, a disease now costing the US $200 billion annually — and likely $1 trillion annually by 2050. The team’s strategies are based on their discovery of a potent neurotoxin that builds up in brain tissue of Alzheimer’s patients.

Dr. Klein is Professor of Neurobiology in Northwestern’s Weinberg College of Arts and Sciences and is a member of the university’s Cognitive Neurology and Alzheimer’s Disease Center. He formerly was director of the Northwestern University interdepartmental program in neuroscience (NUIN). Before coming to Northwestern, Dr. Klein trained with Nobel Prize Winners Paul Boyer (at UCLA) and Marshall Nirenberg (at NIH). He is co-founder of Acumen Pharmaceuticals, a biotech licensed by Northwestern to develop antibodies against Abeta oligomers for Alzheimer’s therapeutics. Dr. Klein is winner of the Zenith Award from the Alzheimer’s Association.

This talk was given at a TEDx event using the TED conference format but independently organized by a local community.